BlackRock ESG Capital Allocation Term Trust Board Gains Key Proxy Advisor Support Against Activist
Summary
BlackRock ESG Capital Allocation Term Trust announced that ISS and Egan-Jones, joining Glass Lewis, recommended shareholders vote for the incumbent board nominees, rejecting the activist investor's slate.
Key Events
-
Proxy Advisors Endorse Incumbent Board
ISS and Egan-Jones recommended shareholders vote for BlackRock's incumbent board nominees, with ISS supporting 7 of 9 and Egan-Jones supporting all 9.
-
Activist Slate Rejected
All three major proxy advisory firms (ISS, Egan-Jones, Glass Lewis) rejected the full slate of nominees proposed by activist investor Saba Capital Management.
-
Shareholder Meeting Nears
The annual meeting is scheduled for June 9, 2026, where shareholders will vote on board nominees.
-
Performance Highlights Cited
The filing cited improved total shareholder return, narrowed NAV discount, increased distribution rates, and share repurchase programs as reasons for supporting the current board.
Analysis
This filing significantly strengthens the incumbent board's position in the ongoing proxy battle with Saba Capital Management. The combined recommendations from ISS, Egan-Jones, and Glass Lewis against the activist's nominees provide a strong endorsement for the current management, making it more likely they will win the upcoming shareholder vote on June 9th.
At the time of this filing, ECAT was trading at $15.79 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.